A paediatric

patient is enrolled in an experimental gene therapy trial for a genetic disease

caused by loss of function in a very large protein. Because the full-length

coding sequence exceeds the packaging capacity of adeno-associated virus (AAV)

vectors, researchers divide the gene into two separate vectors and incorporate

intein sequences to restore protein function after delivery.

What

makes inteins especially valuable for this gene therapy strategy?